A big thank you to all our sponsors, exhibitors and attendees. Cantech 2019 was a great success!
Eden’s experience includes two decades of Portfolio and Hedge Fund Money Management, Options Strategist, Derivatives & Biotech Analyst and Portfolio Manager. He has managed and traded an options book spanning 250+ securities globally and 4 commodities, with open interest of 500,000 contracts in addition to 14 Covered Call ETFs (over $0.5 Billion AUM) in Canada, US & Australia employing his dynamic options writing discipline at Horizons Exchange Traded Funds.
Eden possesses a Top Quartile 5-year, 5-Star growth fund Portfolio Manager track record on over $1 billion in assets across 4 mandates at RBC Global Asset Management. In addition, Eden has delivered a +26% compounded annual return across a Biotechnology mandate between 1995-2003. He also has extensive institutional hedging experience through major crises, and the structuring of Notes to create specific payoff profiles.
Eden is the Portfolio Manager for the Next Edge Biotech Plus fund, the only fully registered Biotech Mutual Fund in Canada. Since inception almost 2 years ago, he has outperformed his benchmark by 25%.